Inhibitory effects of rosiglitazone on paraquat-induced acute lung injury in rats

التفاصيل البيبلوغرافية
العنوان: Inhibitory effects of rosiglitazone on paraquat-induced acute lung injury in rats
المؤلفون: Wei-jian Hou, Zhenning Liu, Shu-ling Bai, Hongyu Zhao, Min Zhao, Qiang Zheng
المصدر: Acta Pharmacologica Sinica. 34:1317-1324
بيانات النشر: Springer Science and Business Media LLC, 2013.
سنة النشر: 2013
مصطلحات موضوعية: Male, Paraquat, Agonist, Time Factors, NF-E2-Related Factor 2, medicine.drug_class, Acute Lung Injury, Interleukin-1beta, Pulmonary Edema, Lung injury, Pharmacology, Rats, Sprague-Dawley, Rosiglitazone, chemistry.chemical_compound, Malondialdehyde, medicine, Animals, Pharmacology (medical), Dose-Response Relationship, Drug, Herbicides, Superoxide Dismutase, Tumor Necrosis Factor-alpha, business.industry, NF-kappa B, General Medicine, Pulmonary edema, medicine.disease, Rats, PPAR gamma, IκBα, Dose–response relationship, chemistry, Anesthesia, Original Article, Thiazolidinediones, business, medicine.drug
الوصف: To investigate the effects of the PPAR-γ agonist rosiglitazone on acute lung injury induced by the herbicide paraquat (PQ) and the underlying mechanisms of action. Male Sprague-Dawley rats were injected with PQ (20 mg/kg, ip). Rosiglitazone (3 or 10 mg/kg, ip) was administered 1 h before PQ exposure. Peripheral blood was collected at 4, 8, 24 and 72 h after PQ exposure for measuring the levels of MDA, TNF-α and IL-1β, and the SOD activity. Lung tissues were collected at 72 h after PQ exposure to determine the wet-to-dry (W/D) ratios and lung injury scores, as well as the protein levels of NF-κBp65, PPAR-γ, Nrf2, IκBα and pIκBα. At 72 h after PQ exposure, the untreated rats showed a 100% cumulative mortality, whereas no death was observed in rosiglitazone-pretreated rats. Moreover, rosiglitazone pretreatment dose-dependently attenuated PQ-induced lung edema and lung histopathological changes. The pretreatment significantly reduced the levels of TNF-α, IL-1β and MDA, increased SOD activity in the peripheral blood of PQ-treated rats. The pretreatment also efficiently activated PPAR-γ, induced Nrf2 expression and inhibited NF-κB activation in the lung tissues of PQ-treated rats. Furthermore, the pretreatment dose-dependently inhibited IκB-α degradation and phosphorylation, thus inhibiting NF-κB activation. Pretreatment with rosiglitazone protects rats against PQ-induced acute lung injury by activating PPAR-γ, inducing Nrf2 expression and inhibiting NF-κB activation.
تدمد: 1745-7254
1671-4083
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc55954045b48abe1fee94483be143a1
https://doi.org/10.1038/aps.2013.65
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....cc55954045b48abe1fee94483be143a1
قاعدة البيانات: OpenAIRE